Deep learning-based clinical decision support system for gastric neoplasms in real-time endoscopy: development and validation study

Endoscopy. 2023 Aug;55(8):701-708. doi: 10.1055/a-2031-0691. Epub 2023 Feb 8.

Abstract

BACKGROUND : Deep learning models have previously been established to predict the histopathology and invasion depth of gastric lesions using endoscopic images. This study aimed to establish and validate a deep learning-based clinical decision support system (CDSS) for the automated detection and classification (diagnosis and invasion depth prediction) of gastric neoplasms in real-time endoscopy. METHODS : The same 5017 endoscopic images that were employed to establish previous models were used for the training data. The primary outcomes were: (i) the lesion detection rate for the detection model, and (ii) the lesion classification accuracy for the classification model. For performance validation of the lesion detection model, 2524 real-time procedures were tested in a randomized pilot study. Consecutive patients were allocated either to CDSS-assisted or conventional screening endoscopy. The lesion detection rate was compared between the groups. For performance validation of the lesion classification model, a prospective multicenter external test was conducted using 3976 novel images from five institutions. RESULTS : The lesion detection rate was 95.6 % (internal test). On performance validation, CDSS-assisted endoscopy showed a higher lesion detection rate than conventional screening endoscopy, although statistically not significant (2.0 % vs. 1.3 %; P = 0.21) (randomized study). The lesion classification rate was 89.7 % in the four-class classification (advanced gastric cancer, early gastric cancer, dysplasia, and non-neoplastic) and 89.2 % in the invasion depth prediction (mucosa confined or submucosa invaded; internal test). On performance validation, the CDSS reached 81.5 % accuracy in the four-class classification and 86.4 % accuracy in the binary classification (prospective multicenter external test). CONCLUSIONS : The CDSS demonstrated its potential for real-life clinical application and high performance in terms of lesion detection and classification of detected lesions in the stomach.

Trial registration: ClinicalTrials.gov NCT05452473.

Publication types

  • Randomized Controlled Trial
  • Multicenter Study
  • Clinical Trial

MeSH terms

  • Decision Support Systems, Clinical*
  • Deep Learning*
  • Endoscopy / methods
  • Endoscopy, Gastrointestinal
  • Humans
  • Pilot Projects
  • Prospective Studies
  • Stomach Neoplasms* / diagnostic imaging
  • Stomach Neoplasms* / pathology

Associated data

  • ClinicalTrials.gov/NCT05452473